The DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.
Characterization and prediction of acute and sustained response to psychedelic psilocybin in a mindfulness group retreat
Open accessAbstract
Meditation and psychedelics have played key roles in humankind’s search for self-transcendence and personal change. However, neither their possible synergistic effects, nor related state and trait predictors have been experimentally studied. To elucidate these issues, we administered double-blind the model psychedelic drug psilocybin (315 μg/kg PO) or placebo to meditators (n = 39) during a 5-day mindfulness group retreat. Psilocybin increased meditation depth and incidence of positively experienced self-dissolution along the perception-hallucination continuum, without concomitant anxiety. Openness, optimism, and emotional reappraisal were predictors of the acute response. Compared with placebo, psilocybin enhanced post-intervention mindfulness and produced larger positive changes in psychosocial functioning at a 4-month follow-up, which were corroborated by external ratings, and associated with magnitude of acute self-dissolution experience. Meditation seems to enhance psilocybin’s positive effects while counteracting possible dysphoric responses. These findings highlight the interactions between non-pharmacological and pharmacological factors, and the role of emotion/attention regulation in shaping the experiential quality of psychedelic states, as well as the experience of selflessness as a modulator of behavior and attitudes. A better comprehension of mechanisms underlying most beneficial psychedelic experiences may guide therapeutic interventions across numerous mental conditions in the form of psychedelic-assisted applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A combination of MM and PAT increases empathy and reduces egocentricity, potentially aiding psychopathology reduction [7].”
From Mindfulness meditation and psychedelics: potential synergies and commonalities (2023) · cites this paper as [7]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The process of decoupling within self-referential networks combined with the alteration in one's sense of self induced by psilocybin during a meditation retreat, can serve as a predictive factor for lasting positive changes in psycho-social well-being [7].”
From Mindfulness meditation and psychedelics: potential synergies and commonalities (2023) · cites this paper as [7]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This was a double-blind, placebo-controlled trial involving 38 participants who were screened with psychometric instruments and in addition with functional magnetic resonance imaging during the resting state and two meditation forms, pre to post-intervention.”
From Mindfulness meditation and psychedelics: potential synergies and commonalities (2023) · cites this paper as [7]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This was effectively demonstrated in three recent studies, which, utilising a combined design, produced beneficial trait-alterations, as well as enhancements in mood, satisfaction with life and behavioural change, which were more significant and longer-lasting than previously observed changes, when each intervention was used in isolation (60–62).”
From Examining the Potential Synergistic Effects Between Mindfulness Training and Psychedelic-Assisted Therapy (2021) · cites this paper as [61]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Hierarchical regression analyses demonstrated that the intensity of mystical experience predicted most positive shifts in trait measures, observed long-term in the aforementioned studies.”
From Examining the Potential Synergistic Effects Between Mindfulness Training and Psychedelic-Assisted Therapy (2021) · cites this paper as [61]
Experimental — accuracy not yet measured
10 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The satisfaction with life scale
Diener, E., Emmons, R. A., Larsen, R. J., & Griffin, S. (1985) · Journal of Personality Assessment · doi:10.1207/s15327752jpa4901_13 · Cited by 31,768
Gross, J. J., & John, O. P. (2003) · Journal of Personality and Social Psychology · doi:10.1037/0022-3514.85.2.348 · Cited by 11,929
Mindfulness-based interventions in context: Past, present, and future
Kabat-Zinn, J. (2003) · Clinical Psychology: Science and Practice · doi:10.1093/clipsy.bpg016 · Cited by 8,615
Mindfulness-based interventions in context: Past, present, and future.
Kabat-Zinn, J. (2003) · Clinical Psychology: Science and Practice · doi:10.1093/clipsy/bpg016 · Cited by 8,612
Scheier, M. F., Carver, C. S., & Bridges, M. W. (1994) · Journal of Personality and Social Psychology · doi:10.1037//0022-3514.67.6.1063 · Cited by 7,456
An Introduction to the Five‐Factor Model and Its Applications
McCrae, R. R., & John, O. P. (1992) · Journal of Personality · doi:10.1111/j.1467-6494.1992.tb00970.x · Cited by 6,835
Mindfulness-based stress reduction and health benefits
Grossman, P., Niemann, L., Schmidt, S., & Walach, H. (2004) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(03)00573-7 · Cited by 3,958
Clinical Psychology: Science and Practice
(2021) · Clinical Psychology Science and Practice · doi:10.1111/(issn)1468-2850 · Cited by 3,672
Hölzel, B. K., Lazar, S. W., Gard, T., Schuman-Olivier, Z., Vago, D. R., & Ott, U. (2011) · Perspectives on Psychological Science · doi:10.1177/1745691611419671 · Cited by 3,024
The Neuroscience of Mindfulness Meditation
Tang, Y.-Y., Hölzel, B. K., & Posner, M. I. (2015) · Nature reviews. Neuroscience · doi:10.1038/nrn3916 · Cited by 2,889
Research works printed but not linked: 15
- Pahnke, W. N. Drugs & Mysticism: An Analysis of the Relationship between Psychedelic Drugs and Mystical Consciousness Divinity. Harvard University, Cambridge MA, 315 (1963).
- Hood, R. W., Hill, P. C. & Spilka, B. The psychology of religion: An empirical approach. (Guilford Press, 2009).
- Nichols, D. E. & Chemel, B. R. The neuropharmacology of religious experience: Hallucinogens and the experience of the divine. Where God and science meet: How brain and evolutionary studies alter our understanding of religion 3, 1–33 (2006).
- Piron, H. The meditation depth index (MEDI) and the meditation depth questionnaire (MEDEQ). Journal for Meditation and Meditation Research 1, 69–92 (2001).
- Hölzel, B. K. & U. O., Relationship between mediation depth, absorption, mediation practice, and mindfullness: A laten variable approach. The Journal of Transpersonal Psychology 38, 20 (2006).
- Studerus, E., Kometer, M., Hasler, F. & Vollenweider, F. X. Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies. J. Psychopharmacol 25, 1434–1452 (2011). · DOI · Paper page
- Rümmele, W. & Gnirss, F. Untersuchungen mit Psilocybin, einer psychotropen Substanz aus Psilocybe Mexicana. Schweiz Arch Neurol Neurochir Psychiatr 87, 365–385 (1961).
- Preller, K. H. & Vollenweider, F. X. In Behavioral Neurobiology of Hallucinogens, Entactogens, and Psychotomimetics Current Topics in Behavioral Neurosciences (eds Halberstadt, A. L., Nichols, D. E. & Vollenweider, F. X.) 360–389 (Springer, 2016).
- Austin, J. H. Zen and the Brain: Toward an Understanding of Meditation and Consciousness. (The MIT Press, 1998). · DOI · Paper page
- Griffiths, R. R., Richards, W. A., McCann, U. & Jesse, R. Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology (Berl) 187, 268–283 (2006). · DOI · Paper page
- Piron, H. Meditation depth, mental health, and personal development. Journal for Meditation and Meditation Research 3, 45–58 (2003).
- Buchheld, N., Grossman, P. & Walach, H. Measuring mindfulness in insight meditation (Vipassana) and meditation-based psychotherapy: The development of the Freiburg Mindfulness Inventory (FMI). Journal for Meditation and Meditation Research 1, 11–34 (2001).
- Derogatis, L. SCL-90-R: Symptom Checklist-90-R: administration, scoring, and procedures manual. NCS Pearson (1996).
- Hood, R. W. Jr. The construction and preliminary validation of a measure of reported mystical experience. Journal for the scientific study of religion, 29–41 (1975). · DOI · Paper page
- Stace, W. (Philadelphia, Lippincott, 1960).
Cited by
Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders
Vollenweider, F. X., & Preller, K. H. (2020) · Nature Reviews Neuroscience · doi:10.1038/s41583-020-0367-2 · Cited by 570
Self-citationThe Therapeutic Potential of Psilocybin
Lowe, H., Toyang, N., Steele, B., Valentine, H., Grant, J., Ali, A., Ngwa, W., & Gordon, L. (2021) · Molecules · doi:10.3390/molecules26102948 · Cited by 242
Pharmacological, neural, and psychological mechanisms underlying psychedelics: A critical review
van Elk, M., & Yaden, D. B. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104793 · Cited by 221
Aday, J. S., Davis, A. K., Mitzkovitz, C. M., Bloesch, E. K., & Davoli, C. C. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.1c00014 · Cited by 224
Madsen, M. K., Fisher, P. M., Stenbæk, D. S., Kristiansen, S., Burmester, D., Lehel, S., Páleníček, T., Kuchař, M., Svarer, C., Ozenne, B., et al. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.02.001 · Cited by 183
Metadata
- Authors
- Smigielski, L., Kometer, M., Scheidegger, M., Krähenmann, R., Huber, T., & Vollenweider, F. X.
- Affiliations
- University of Zurich (CH)
- Corresponding author
- Smigielski, Lukasz
- Venue
- Scientific Reports
- Published
- 2019-10-24
- Volume
- 9
- Issue
- 1
- Pages
- 14914-14914
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC6813317
- OpenAlex
- W2981695213
- Semantic Scholar
- fcd7b11b16450124bf47adf83ecef65b0ff6420b
- Cited by
- 176
- References
- 95
- Citations by year
- 2026: 18 · 2025: 31 · 2024: 24 · 2023: 44 · 2022: 32 · 2021: 15 · 2020: 8 · 2019: 2
- FWCI
- 16.64
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, cc-by)
- Funders
- Swiss Neuromatrix Foundation
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Social Sciences › Psychology › Social Psychology › Paranormal Experiences and Beliefs
- Social Sciences › Health › Religion, Spirituality, and Psychology
- Keywords
- psilocybin, mindfulness meditation, psychedelic therapy, dissolution of the self, self-transcendence, openness to experience, optimism, emotional reappraisal, emotion regulation, placebo response
- MeSH terms
- Attention, Buddhism, Emotions, Female, Hallucinogens, Humans, Male, Middle Aged, Psilocybin, Social Behavior, Meditation, Mindfulness
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Characterization and prediction of acute and sustained response to psychedelic psilocybin in a mindfulness group retreat. https://app.cochat.ai/papers/10.1038/s41598-019-50612-3
- The paper
- Smigielski, L., Kometer, M., Scheidegger, M., Krähenmann, R., Huber, T., & Vollenweider, F. X. (2019). Characterization and prediction of acute and sustained response to psychedelic psilocybin in a mindfulness group retreat. Scientific Reports. https://doi.org/10.1038/s41598-019-50612-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.